Literature DB >> 18322445

Cost of vaccinating refugees overseas versus after arrival in the United States, 2005.

.   

Abstract

Since 2000, approximately 50,000 refugees have entered the United States each year from various regions of the world. Although persons with immigrant status are legally required to be vaccinated before entering the United States, this requirement does not extend to U.S.-bound persons with refugee status. After 1 year in the United States, refugees can apply for a change of status to that of legal permanent resident, at which time they are required to be fully vaccinated in accordance with recommendations of the Advisory Committee on Immunization Practices (ACIP). A potentially less costly alternative might be to vaccinate U.S.-bound refugees overseas routinely, before they depart from refugee camps. To compare the cost of vaccinating refugees overseas versus after their arrival in the United States, CDC analyzed 2005 data on the number of refugees, cost of vaccine, and cost of vaccine administration. This report summarizes the results of that analysis, which suggested that, in 2005, vaccinating 50,787 refugees overseas would have cost an estimated $7.7 million, less than one third of the estimated $26.0 million cost of vaccinating in the United States. Costs were calculated from the perspective of the U.S. health-care system. To achieve public health cost savings, routine overseas vaccination of U.S.-bound refugees should be considered.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18322445

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  8 in total

1.  The global dimensions of public health preparedness and implications for US action.

Authors:  Melinda Moore
Journal:  Am J Public Health       Date:  2012-04-19       Impact factor: 9.308

2.  Enhancing the work of the Department of Health and Human Services national vaccine program in global immunization: recommendations of the National Vaccine Advisory Committee: approved by the National Vaccine Advisory Committee on September 12, 2013.

Authors: 
Journal:  Public Health Rep       Date:  2014       Impact factor: 2.792

3.  A comparative cost analysis of the Vaccination Program for US-bound Refugees.

Authors:  Heesoo Joo; Brian Maskery; Tarissa Mitchell; Andrew Leidner; Alexander Klosovsky; Michelle Weinberg
Journal:  Vaccine       Date:  2017-09-14       Impact factor: 3.641

4.  Cost-benefit comparison of two proposed overseas programs for reducing chronic Hepatitis B infection among refugees: is screening essential?

Authors:  Amelia Jazwa; Margaret S Coleman; Julie Gazmararian; La'Marcus T Wingate; Brian Maskery; Tarissa Mitchell; Michelle Weinberg
Journal:  Vaccine       Date:  2015-01-14       Impact factor: 3.641

5.  Factors associated with hepatitis B testing among Vietnamese Americans.

Authors:  Tung T Nguyen; Stephen J McPhee; Susan Stewart; Ginny Gildengorin; Lena Zhang; Ching Wong; Annette E Maxwell; Roshan Bastani; Vicky M Taylor; Moon S Chen
Journal:  J Gen Intern Med       Date:  2010-03-20       Impact factor: 5.128

6.  Seroprevalence of varicella-zoster virus in five US-bound refugee populations.

Authors:  Jessica Leung; Adriana Lopez; Tarissa Mitchell; Michelle Weinberg; Deborah Lee; Martha Thieme; D Scott Schmid; Stephanie R Bialek
Journal:  J Immigr Minor Health       Date:  2015-02

7.  Varicella zoster virus-associated morbidity and mortality in Africa - a systematic review.

Authors:  Hannah Hussey; Leila Abdullahi; Jamie Collins; Rudzani Muloiwa; Gregory Hussey; Benjamin Kagina
Journal:  BMC Infect Dis       Date:  2017-11-14       Impact factor: 3.090

8.  Role of immigrants and migrants in emerging infectious diseases.

Authors:  Elizabeth D Barnett; Patricia F Walker
Journal:  Med Clin North Am       Date:  2008-11       Impact factor: 5.456

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.